metastatic colorectal cancer

November 20, 2018November 20, 2018

Celyad’s CAR T-Cell Therapy, CYAD-01, Showing Early Signs of Efficacy in Advanced Colorectal Cancer

News

CYAD-01 — Celyad‘s CAR T-cell product — is showing promise as a treatment for metastatic colorectal cancer patients (mCRC), both alone and in combination with standard of care chemotherapy, according to ... Read more

October 26, 2018

Opdivo-Yervoy Combo Shows Potential as First-line Treatment for Certain Colorectal Cancers

News

A combination of Bristol-Myers Squibb‘s Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) induced promising and durable response rates in metastatic colorectal cancer patients with certain genetic abnormalities who had not received prior ... Read more

May 16, 2018May 16, 2018

Humanized CAR T-cell Therapy Seen to Treat Metastatic Colorectal Cancer in Mouse Study

News

A humanized chimeric antigen receptor (CAR) T-cell immunotherapy was seen successfully kill tumor cells and prevent further spread of colorectal metastatic cancer in mouse models of the disease. The treatment, which ... Read more

February 7, 2018February 7, 2018

Opdivo-Yervoy Combo Shows Promise for Treating Certain Colorectal Cancers

News

A combination of the immune checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) induces durable responses in patients with metastatic colorectal cancer with certain genetic features, a Phase 2 clinical trial shows. ... Read more

June 8, 2016June 8, 2016

Immuno-oncology Study Shows Genes May Predict Treatment Results for Colorectal Cancer

News

During the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting, a study revealed that immune-related genes could predict outcomes of cetuximab treatment for metastatic colorectal cancer. The study, “Immune-related genes to ... Read more

May 14, 2015May 14, 2015

First-In-Class Antibody Mixture Reduces Tumor Colorectal Cancer Progression

News

This week, researchers from the Vall d’Hebron University (VHU) Hospital’s Vall d’Hebron Institute of Oncology (VHIO) in Barcelona, Spain, have released results from a study showing that a therapeutic agent ... Read more

March 6, 2015March 6, 2015

Vectibix Combined with FOLFIRI Chemotherapy as First-Line Therapy For Metastatic Colorectal Cancer

News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) gave a positive opinion to extend the marketing authorization for Vectibix (panitumumab) (Amgen) to be included ... Read more